{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T03:12:31Z","timestamp":1789096351061,"version":"build-2803163510"},"reference-count":133,"publisher":"Oxford University Press (OUP)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1111\/j.1753-4887.2012.00484.x","type":"journal-article","created":{"date-parts":[[2012,5,22]],"date-time":"2012-05-22T16:25:04Z","timestamp":1337703904000},"page":"373-386","source":"Crossref","is-referenced-by-count":68,"title":["Nutraceuticals and their preventive or potential therapeutic value in Parkinson's disease"],"prefix":"10.1093","volume":"70","author":[{"given":"Jianfei","family":"Chao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingfu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond Chuen-Chung","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2012,5,22]]},"reference":[{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/mds.10305","article-title":"Systematic review of incidence studies of Parkinson's disease","volume":"18","author":"Twelves","year":"2003","journal-title":"Mov Disord."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1002\/mds.21009","article-title":"Chemical exposures and Parkinson's disease: a population-based case-control study","volume":"21","author":"Frigerio","year":"2006","journal-title":"Mov Disord."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/ana.20904","article-title":"Pesticide exposure and risk for Parkinson's disease","volume":"60","author":"Ascherio","year":"2006","journal-title":"Ann Neurol."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.nbd.2005.03.018","article-title":"Systemic exposure to paraquat and maneb models early Parkinson's disease in young adult rats","volume":"20","author":"Cicchetti","year":"2005","journal-title":"Neurobiol Dis."},{"issue":"1","key":"10.1111\/j.1753-4887.2012.00484.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1002\/mds.22796","article-title":"Parkinson's disease: 10 years of progress, 1997-2007","volume":"25","author":"Fahn","year":"2010","journal-title":"Mov Disord."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1111\/j.1468-1331.2009.02793.x","article-title":"Perspectives on recent advances in the understanding and treatment of Parkinson's disease","volume":"16","author":"Schapira","year":"2009","journal-title":"Eur J Neurol."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0197-4580(02)00076-3","article-title":"Protein misfolding in Alzheimer's and Parkinson's disease: genetics and molecular mechanisms","volume":"23","author":"Forloni","year":"2002","journal-title":"Neurobiol Aging."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/S1474-4422(07)70076-5","article-title":"Autophagy and neurodegeneration: when the cleaning crew goes on strike","volume":"6","author":"Martinez-Vicente","year":"2007","journal-title":"Lancet Neurol."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1038\/nature05291","article-title":"The roles of intracellular protein-degradation pathways in neurodegeneration","volume":"443","author":"Rubinsztein","year":"2006","journal-title":"Nature."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1111\/j.1471-4159.2006.03907.x","article-title":"Oxidative stress and neurodegeneration: where are we now?","volume":"97","author":"Halliwell","year":"2006","journal-title":"J Neurochem."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/scientificamerican0197-52","article-title":"Understanding Parkinson's disease","volume":"276","author":"Youdim","year":"1997","journal-title":"Sci Am."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0304-3940(01)02514-9","article-title":"Hydroxynonenal adducts indicate a role for lipid peroxidation in neocortical and brainstem Lewy bodies in humans","volume":"319","author":"Castellani","year":"2002","journal-title":"Neurosci Lett."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB13|cit13","first-page":"60","article-title":"Free radical toxicity and antioxidants in Parkinson's disease","volume":"51","author":"Sudha","year":"2003","journal-title":"Neurol India."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"8161","DOI":"10.1073\/pnas.0609874104","article-title":"Two molecular pathways initiate mitochondria-dependent dopaminergic neurodegeneration in experimental Parkinson's disease","volume":"104","author":"Perier","year":"2007","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB15|cit15","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1749-6632.2003.tb07470.x","article-title":"Mitochondria, oxidative damage, and inflammation in Parkinson's disease","volume":"91","author":"Beal","year":"2003","journal-title":"Ann N Y Acad Sci."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"2875","DOI":"10.1073\/pnas.040556597","article-title":"Caspase-3: a vulnerability factor and final effector in apoptotic death of dopaminergic neurons in Parkinson's disease","volume":"97","author":"Hartmann","year":"2000","journal-title":"Proc Natl Acad Sci U S A."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1126\/science.6823561","article-title":"Chronic parkinsonism in humans due to a product of meperidine-analog synthesis","volume":"219","author":"Langston","year":"1983","journal-title":"Science."},{"issue":"2","key":"10.1111\/j.1753-4887.2012.00484.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"II63","DOI":"10.1007\/PL00007763","article-title":"Mitochondrial dysfunction - a pathogenetic factor in Parkinson's disease","volume":"247","author":"Reichmann","year":"2000","journal-title":"J Neurol."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/978-1-59745-521-3_11","article-title":"Reactive oxygen species production by mitochondria","volume":"554","author":"Lambert","year":"2009","journal-title":"Methods Mol Biol."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jneumeth.2004.08.004","article-title":"Evaluation of animal models of Parkinson's disease for neuroprotective strategies","volume":"139","author":"Emborg","year":"2004","journal-title":"J Neurosci Methods."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/10284150500047161","article-title":"Reducing mitochondrial decay with mitochondrial nutrients to delay and treat cognitive dysfunction, Alzheimer's disease, and Parkinson's disease","volume":"8","author":"Liu","year":"2005","journal-title":"Nutr Neurosci."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.tig.2008.11.007","article-title":"Mitochondrial DNA mutations and aging: devils in the details?","volume":"25","author":"Khrapko","year":"2009","journal-title":"Trends Genet."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1365-2796.2007.01905.x","article-title":"Mitochondrial dysfunction as a cause of ageing","volume":"263","author":"Trifunovic","year":"2008","journal-title":"J Intern Med."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.1007\/s11064-008-9747-0","article-title":"Generation of reactive oxygen species by mitochondrial complex I: implications in neurodegeneration","volume":"33","author":"Fato","year":"2008","journal-title":"Neurochem Res."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB25|cit25","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.nbd.2005.12.008","article-title":"Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease","volume":"22","author":"Chaturvedi","year":"2006","journal-title":"Neurobiol Dis."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2165\/00002018-199921040-00002","article-title":"Antioxidant vitamin supplements: update of their potential benefits and possible risks","volume":"21","author":"Maxwell","year":"1999","journal-title":"Drug Saf."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB27|cit27","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/1531-8257(199901)14:1<21::AID-MDS1006>3.0.CO;2-Y","article-title":"Dietary factors in Parkinson's disease: the role of food groups and specific foods","volume":"14","author":"Anderson","year":"1999","journal-title":"Mov Disord."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"S380","DOI":"10.1093\/ajcn\/53.1.380S","article-title":"An open trial of high-dosage antioxidants in early Parkinson's disease","volume":"53","author":"Fahn","year":"1991","journal-title":"Am J Clin Nutr."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1301\/002966402320583433","article-title":"Roles of vitamins E and C on neurodegenerative diseases and cognitive performance","volume":"60","author":"Martin","year":"2002","journal-title":"Nutr Rev."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1056\/NEJM199301213280305","article-title":"Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease","volume":"328","author":"The Parkinson Study Group","year":"1993","journal-title":"N Engl J Med."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S1474-4422(03)00300-4","article-title":"Dietary vitamin E and Parkinson's disease: something to chew on","volume":"2","author":"Olanow","year":"2003","journal-title":"Lancet Neurol."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1212\/01.WNL.0000028688.75881.12","article-title":"Intakes of vitamins E and C, carotenoids, vitamin supplements, and PD risk","volume":"59","author":"Zhang","year":"2002","journal-title":"Neurology."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S1474-4422(05)70097-1","article-title":"Intake of vitamin E, vitamin C, and carotenoids and the risk of Parkinson's disease: a meta-analysis","volume":"4","author":"Etminan","year":"2005","journal-title":"Lancet Neurol."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/mds.870120209","article-title":"Dietary antioxidants and other dietary factors in the etiology of Parkinson's disease","volume":"12","author":"Scheider","year":"1997","journal-title":"Mov Disord."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/00017285-200611000-00003","article-title":"The state of antioxidant affairs","volume":"41","author":"Verhagen","year":"2006","journal-title":"Nutr Today."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB36|cit36","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/mds.21317","article-title":"Vitamin D and Parkinson's disease - a hypothesis","volume":"22","author":"Newmark","year":"2007","journal-title":"Mov Disord."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0006-8993(01)02450-7","article-title":"Vitamin D attenuates 6-hydroxydopamine-induced neurotoxicity 3 in rats","volume":"904","author":"Wang","year":"2001","journal-title":"Brain Res."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1002\/1097-4547(20001101)62:3<374::AID-JNR7>3.0.CO;2-7","article-title":"Effect of 1,25-dihydroxyvitamin D3 on cultured mesencephalic dopaminergic neurons to the combined toxicity caused by L-buthionine sulfoximine and 1-methyl-4-phenylpyridine","volume":"62","author":"Shinpo","year":"2000","journal-title":"J Neurosci Res."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB39|cit39","first-page":"526","article-title":"CSF multianalyte profile distinguishes Alzheimer and Parkinson diseases","volume":"129","author":"Zhang","year":"2008","journal-title":"Clin Chem."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1001\/archneurol.2010.120","article-title":"Serum vitamin D and the risk of Parkinson disease","volume":"67","author":"Knekt","year":"2010","journal-title":"Arch Neurol."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB41|cit41","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1046\/j.0953-816x.2001.01534.x","article-title":"Delayed infusion of GDNF promotes recovery of motor function in the partial lesion model of Parkinson's disease","volume":"13","author":"Kirik","year":"2001","journal-title":"Eur J Neurosci."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S1043-2760(01)00547-1","article-title":"New clues about vitamin D functions in the nervous system","volume":"13","author":"Garcion","year":"2002","journal-title":"Trends Endocrinol Metab."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1001\/archneur.65.10.1348","article-title":"Prevalence of vitamin D insufficiency in patients with Parkinson disease and Alzheimer disease","volume":"65","author":"Evatt","year":"2008","journal-title":"Arch Neurol."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.pharmthera.2005.02.002","article-title":"Therapeutic role of coenzyme Q(10) in Parkinson's disease","volume":"107","author":"Shults","year":"2005","journal-title":"Pharmacol Ther."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0006-8993(97)01192-X","article-title":"Coenzyme Q10 attenuates the 1-methyl-4-phenyl-1,2,3,tetrahydropyridine (MPTP) induced loss of striatal dopamine and dopaminergic axons in aged mice","volume":"783","author":"Beal","year":"1998","journal-title":"Brain Res."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1111\/j.1471-4159.2007.05097.x","article-title":"Therapeutic effects of coenzyme Q10 (CoQ10) and reduced CoQ10 in the MPTP model of Parkinsonism","volume":"104","author":"Cleren","year":"2008","journal-title":"J Neurochem."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB47|cit47","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1001\/archneur.59.10.1541","article-title":"Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline","volume":"59","author":"Shults","year":"2002","journal-title":"Arch Neurol."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB48|cit48","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0304-3940(03)00185-X","article-title":"Coenzyme Q10 supplementation provides mild symptomatic benefit in patients with Parkinson's disease","volume":"341","author":"Muller","year":"2003","journal-title":"Neurosci Lett."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB49|cit49","first-page":"1065","article-title":"Coenzyme Q10","volume":"72","author":"Bonakdar","year":"2005","journal-title":"Am Fam Physician."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB50|cit50","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/biof.5520090223","article-title":"A possible role of coenzyme Q10 in the etiology and treatment of Parkinson's disease","volume":"9","author":"Shults","year":"1999","journal-title":"Biofactors."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB51|cit51","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1006\/exnr.1999.7049","article-title":"Creatine and cyclocreatine attenuate MPTP neurotoxicity","volume":"157","author":"Matthews","year":"1999","journal-title":"Exp Neurol."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB52|cit52","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1212\/01.wnl.0000238518.34389.12","article-title":"Creatine supplementation in Parkinson disease: a placebo-controlled randomized pilot trial","volume":"67","author":"Bender","year":"2006","journal-title":"Neurology."},{"issue":"3","key":"10.1111\/j.1753-4887.2012.00484.x-BIB53|cit53","doi-asserted-by":"crossref","first-page":"S189","DOI":"10.1016\/S1353-8020(09)70812-0","article-title":"Therapeutic approaches to mitochondrial dysfunction in Parkinson's disease","volume":"15","author":"Beal","year":"2009","journal-title":"Parkinsonism Relat Disord."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB54|cit54","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.bbr.2008.08.004","article-title":"Oral creatine supplementation attenuates L-dopa-induced dyskinesia in 6-hydroxydopamine-lesioned rats","volume":"197","author":"Valastro","year":"2009","journal-title":"Behav Brain Res."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB55|cit55","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1212\/01.WNL.0000166038.67153.9F","article-title":"Dietary fatty acids and the risk of Parkinson disease: the Rotterdam Study","volume":"64","author":"de Lau","year":"2005","journal-title":"Neurology."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB56|cit56","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1093\/aje\/kwg073","article-title":"Dietary intakes of fat and risk of Parkinson's disease","volume":"157","author":"Chen","year":"2003","journal-title":"Am J Epidemiol."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB57|cit57","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1096\/fj.07-9677com","article-title":"Beneficial effects of dietary omega-3 polyunsaturated fatty acid on toxin-induced neuronal degeneration in an animal model of Parkinson's disease","volume":"22","author":"Bousquet","year":"2008","journal-title":"FASEB J."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB58|cit58","doi-asserted-by":"crossref","first-page":"S1669","DOI":"10.1093\/ajcn\/71.6.1669S","article-title":"Can nutrient supplements modify brain function?","volume":"71","author":"Fernstrom","year":"2000","journal-title":"Am J Clin Nutr."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB59|cit59","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1093\/ajcn\/70.6.1009","article-title":"High-monounsaturated fatty acid diets lower both plasma cholesterol and triacylglycerol concentrations","volume":"70","author":"Kris-Etherton","year":"1999","journal-title":"Am J Clin Nutr."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB60|cit60","doi-asserted-by":"crossref","first-page":"432","DOI":"10.2174\/187152709789824642","article-title":"Cannabinoids and Parkinson's disease","volume":"8","author":"Garcia-Arencibia","year":"2009","journal-title":"CNS Neurol Disord Drug Targets."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB61|cit61","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.neuint.2005.12.002","article-title":"Postmortem brain fatty acid profile of levodopa-treated Parkinson disease patients and parkinsonian monkeys","volume":"48","author":"Julien","year":"2006","journal-title":"Neurochem Int."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB62|cit62","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/mds.870050112","article-title":"Paralysis agitans and levodopa in \u201cAyurveda\u201d: ancient Indian medical treatise","volume":"5","author":"Manyam","year":"1990","journal-title":"Mov Disord."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB63|cit63","first-page":"565","article-title":"Traditional and complementary therapies in Parkinson's disease","volume":"80","author":"Manyam","year":"1999","journal-title":"Adv Neurol."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB64|cit64","first-page":"171","article-title":"Treatment of Parkinson's disease with the cowhage plant -Mucuna pruriens Bak","volume":"26","author":"Vaidya","year":"1978","journal-title":"Neurol India."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB65|cit65","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0022-510X(00)00329-4","article-title":"Association of L-dopa with recovery following Ayurveda medication in Parkinson's disease","volume":"176","author":"Nagashayana","year":"2000","journal-title":"J Neurol Sci."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB66|cit66","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1089\/acm.1995.1.249","article-title":"An alternative medicine treatment for Parkinson's disease: results of a multicenter clinical trial","volume":"1","author":"HP200 in Parkinson's Disease Study Group","year":"1995","journal-title":"J Altern Complement Med."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB67|cit67","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1136\/jnnp.2003.028761","article-title":"Mucuna pruriens in Parkinson's disease: a double blind clinical and pharmacological study","volume":"75","author":"Katzenschlager","year":"2004","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB68|cit68","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1002\/ptr.1514","article-title":"Neuroprotective effects of the antiparkinson drug Mucuna pruriens","volume":"18","author":"Manyam","year":"2004","journal-title":"Phytother Res."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB69|cit69","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1002\/ptr.2219","article-title":"Anti-Parkinson botanical Mucuna pruriens prevents levodopa induced plasmid and genomic DNA damage","volume":"21","author":"Tharakan","year":"2007","journal-title":"Phytother Res."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB70|cit70","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/0014-5793(94)01056-0","article-title":"Intense oxidative DNA damage promoted by L-dopa and its metabolites. Implications for neurodegenerative disease","volume":"353","author":"Spencer","year":"1994","journal-title":"FEBS Lett."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB71|cit71","doi-asserted-by":"crossref","first-page":"55","DOI":"10.4067\/S0716-97602000000200004","article-title":"Plant polyphenol antioxidants and oxidative stress","volume":"33","author":"Urquiaga","year":"2000","journal-title":"Biol Res."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB72|cit72","doi-asserted-by":"crossref","first-page":"711","DOI":"10.2165\/00002512-200320100-00001","article-title":"Potential therapeutic properties of green tea polyphenols in Parkinson's disease","volume":"20","author":"Pan","year":"2003","journal-title":"Drugs Aging."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB73|cit73","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1046\/j.1471-4159.2003.02291.x","article-title":"Cell signaling pathways in the neuroprotective actions of the green tea polyphenol (-)-epigallocatechin-3-gallate: implications for neurodegenerative diseases","volume":"88","author":"Mandel","year":"2004","journal-title":"J Neurochem."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB74|cit74","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jnutbio.2004.05.002","article-title":"Neurological mechanisms of green tea polyphenols in Alzheimer's and Parkinson's diseases","volume":"15","author":"Weinreb","year":"2004","journal-title":"J Nutr Biochem."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB75|cit75","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1046\/j.1471-4159.2001.00490.x","article-title":"Green tea polyphenol (-)-epigallocatechin-3-gallate prevents N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurodegeneration","volume":"78","author":"Levites","year":"2001","journal-title":"J Neurochem."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB76|cit76","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/978-3-211-33328-0_26","article-title":"Green tea catechins as brain-permeable, non toxic iron chelators to \u201ciron out iron\u201d from the brain","volume":"71","author":"Mandel","year":"2006","journal-title":"J Neural Transm Suppl."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB77|cit77","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/j.biopsych.2007.04.020","article-title":"Protective effects of green tea polyphenols in the 6-OHDA rat model of Parkinson's disease through inhibition of ROS-NO pathway","volume":"62","author":"Guo","year":"2007","journal-title":"Biol Psychiatry."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB78|cit78","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1093\/aje\/kwm338","article-title":"Differential effects of black versus green tea on risk of Parkinson's disease in the Singapore Chinese Health Study","volume":"167","author":"Tan","year":"2008","journal-title":"Am J Epidemiol."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB79|cit79","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.freeradbiomed.2007.11.011","article-title":"Curcumin treatment alleviates the effects of glutathione depletion in vitro and in vivo: therapeutic implications for Parkinson's disease explained via in silico studies","volume":"44","author":"Jagatha","year":"2008","journal-title":"Free Radic Biol Med."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB80|cit80","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1080\/10715760500233113","article-title":"Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinson's disease","volume":"39","author":"Zbarsky","year":"2005","journal-title":"Free Radic Res."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB81|cit81","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.bcp.2009.03.031","article-title":"Curcumin attenuates 6-hydroxydopamine-induced cytotoxicity by anti-oxidation and nuclear factor-kappa B modulation in MES23.5 cells","volume":"78","author":"Wang","year":"2009","journal-title":"Biochem Pharmacol."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB82|cit82","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1007\/s11064-008-9675-z","article-title":"Curcumin protects dopaminergic neuron against LPS induced neurotoxicity in primary rat neuron\/glia culture","volume":"33","author":"Yang","year":"2008","journal-title":"Neurochem Res."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB83|cit83","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1089\/rej.2009.0908","article-title":"Curcumin prevents dopaminergic neuronal death through inhibition of the c-Jun N-terminal kinase pathway","volume":"13","author":"Yu","year":"2010","journal-title":"Rejuvenation Res."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB84|cit84","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1007\/s10495-006-6715-5","article-title":"Curcumin protects PC12 cells against 1-methyl-4-phenylpyridinium ion-induced apoptosis by bcl-2-mitochondria-ROS-iNOS pathway","volume":"11","author":"Chen","year":"2006","journal-title":"Apoptosis."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB85|cit85","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s10787-007-1614-0","article-title":"Inhibition of monoamine oxidase-B by the polyphenolic compound, curcumin and its metabolite tetrahydrocurcumin, in a model of Parkinson's disease induced by MPTP neurodegeneration in mice","volume":"16","author":"Rajeswari","year":"2008","journal-title":"Inflammopharmacology."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB86|cit86","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1471-2202-11-57","article-title":"Curcumin reduces alpha-synuclein induced cytotoxicity in Parkinson's disease cell model","volume":"11","author":"Wang","year":"2010","journal-title":"BMC Neurosci."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB87|cit87","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00401-007-0332-4","article-title":"Curcumin inhibits aggregation of alpha-synuclein","volume":"115","author":"Pandey","year":"2008","journal-title":"Acta Neuropathol."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB88|cit88","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.neuro.2009.07.016","article-title":"Curcumin enhances paraquat-induced apoptosis of N27 mesencephalic cells via the generation of reactive oxygen species","volume":"30","author":"Ortiz-Ortiz","year":"2009","journal-title":"Neurotoxicology."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB89|cit89","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.neulet.2009.10.081","article-title":"Curcumin exposure induces expression of the Parkinson's disease-associated leucine-rich repeat kinase 2 (LRRK2) in rat mesencephalic cells","volume":"468","author":"Ortiz-Ortiz","year":"2010","journal-title":"Neurosci Lett."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB90|cit90","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1161\/01.STR.0000249004.25444.a5","article-title":"Baicalein and 12\/15-lipoxygenase in the ischemic brain","volume":"37","author":"van Leyen","year":"2006","journal-title":"Stroke."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB91|cit91","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1038\/bjp.2008.345","article-title":"Post-injury baicalein improves histological and functional outcomes and reduces inflammatory cytokines after experimental traumatic brain injury","volume":"155","author":"Chen","year":"2008","journal-title":"Br J Pharmacol."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB92|cit92","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.neulet.2008.05.116","article-title":"Neuroprotective effect of baicalein against MPTP neurotoxicity: behavioral, biochemical and immunohistochemical profile","volume":"441","author":"Cheng","year":"2008","journal-title":"Neurosci Lett."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB93|cit93","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.pbb.2009.03.008","article-title":"Baicalein exerts neuroprotective effects in 6-hydroxydopamine-induced experimental parkinsonism in vivo and in vitro","volume":"92","author":"Mu","year":"2009","journal-title":"Pharmacol Biochem Behav."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB94|cit94","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.bbrc.2009.12.079","article-title":"Residue Glu83 plays a major role in negatively regulating a-synuclein amyloid formation","volume":"391","author":"Waxman","year":"2010","journal-title":"Biochem Bioph Res Commun."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB95|cit95","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1471-4159.2010.06752.x","article-title":"Baicalein reduces E46K alpha-synuclein aggregation in vitro and protects cells against E46K alpha-synuclein toxicity in cell models of familiar Parkinsonism","volume":"114","author":"Jiang","year":"2010","journal-title":"J Neurochem."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB96|cit96","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0024-3205(99)00410-5","article-title":"Biological effects of resveratrol","volume":"66","author":"Fremont","year":"2000","journal-title":"Life Sci."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB97|cit97","doi-asserted-by":"crossref","first-page":"3337","DOI":"10.1021\/jf0112973","article-title":"Plant foods and herbal sources of resveratrol","volume":"50","author":"Burns","year":"2002","journal-title":"J Agric Food Chem."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB98|cit98","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1089\/152308601317203567","article-title":"Biological effects of resveratrol","volume":"3","author":"Bhat","year":"2001","journal-title":"Antioxid Redox Signal."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB99|cit99","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1124\/mol.110.064535","article-title":"Resveratrol protects dopamine neurons against lipopolysaccharide-induced neurotoxicity through its anti-inflammatory actions","volume":"78","author":"Zhang","year":"2010","journal-title":"Mol Pharmacol."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB100|cit100","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1007\/s10571-009-9411-5","article-title":"Protective effects of resveratrol and quercetin against MPP+ -induced oxidative stress act by modulating markers of apoptotic death in dopaminergic neurons","volume":"29","author":"Bournival","year":"2009","journal-title":"Cell Mol Neurobiol."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB101|cit101","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/emm.2007.42","article-title":"Resveratrol protects SH-SY5Y neuroblastoma cells from apoptosis induced by dopamine","volume":"39","author":"Lee","year":"2007","journal-title":"Exp Mol Med."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB102|cit102","doi-asserted-by":"crossref","first-page":"6910","DOI":"10.1021\/jf8007212","article-title":"Neuroprotective effects of resveratrol on MPTP-induced neuron loss mediated by free radical scavenging","volume":"56","author":"Lu","year":"2008","journal-title":"J Agric Food Chem."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB103|cit103","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.brainres.2010.02.031","article-title":"Resveratrol attenuates 6-hydroxydopamine-induced oxidative damage and dopamine depletion in rat model of Parkinson's disease","volume":"1328","author":"Khan","year":"2010","journal-title":"Brain Res."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB104|cit104","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/jnr.21503","article-title":"Resveratrol and quercetin, two natural polyphenols, reduce apoptotic neuronal cell death induced by neuroinflammation","volume":"86","author":"Bureau","year":"2008","journal-title":"J Neurosci Res."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB105|cit105","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1111\/j.1471-4159.2009.06228.x","article-title":"The SIRT1 activator resveratrol protects SK-N-BE cells from oxidative stress and against toxicity caused by alpha-synuclein or amyloid-beta (1-42) peptide","volume":"110","author":"Albani","year":"2009","journal-title":"J Neurochem."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB106|cit106","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2174\/157488908783421492","article-title":"Modulation of sirtuins: new targets for antiageing","volume":"3","author":"Pallas","year":"2008","journal-title":"Recent Pat CNS Drug Discov."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB107|cit107","doi-asserted-by":"crossref","first-page":"70","DOI":"10.2174\/156720209787466019","article-title":"Resveratrol and neurodegenerative diseases: activation of SIRT1 as the potential pathway towards neuroprotection","volume":"6","author":"Pallas","year":"2009","journal-title":"Curr Neurovasc Res."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB108|cit108","doi-asserted-by":"crossref","first-page":"4463","DOI":"10.1021\/jf800444g","article-title":"Anti-inflammatory effects of phenolic compounds isolated from the fruits of Artocarpus heterophyllus","volume":"56","author":"Fang","year":"2008","journal-title":"J Agric Food Chem."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB109|cit109","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1021\/np010451c","article-title":"Constituents of the bark and twigs of Artocarpus dadah with cyclooxygenase inhibitory activity","volume":"65","author":"Su","year":"2002","journal-title":"J Nat Prod."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB110|cit110","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.phymed.2006.09.003","article-title":"Beta-secretase (BACE1)-inhibiting stilbenoids from Smilax Rhizoma","volume":"14","author":"Jeon","year":"2007","journal-title":"Phytomedicine."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB111|cit111","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.freeradbiomed.2008.07.002","article-title":"Dietary oxyresveratrol prevents parkinsonian mimetic 6-hydroxydopamine neurotoxicity","volume":"45","author":"Chao","year":"2008","journal-title":"Free Radic Biol Med."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB112|cit112","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/j.1476-5381.2009.00361.x","article-title":"Ginsenoside Rg1 protects dopaminergic neurons in a rat model of Parkinson's disease through the IGF-I receptor signalling pathway","volume":"158","author":"Xu","year":"2009","journal-title":"Br J Pharmacol."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB113|cit113","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.expneurol.2010.05.015","article-title":"Estrogen and angiotensin interaction in the substantia nigra. Relevance to postmenopausal Parkinson's disease","volume":"224","author":"Rodriguez-Perez","year":"2010","journal-title":"Exp Neurol."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB114|cit114","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1385\/ENDO:21:1:77","article-title":"Estrogens and Parkinson disease: novel approach for neuroprotection","volume":"21","author":"Sawada","year":"2003","journal-title":"Endocrine."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB115|cit115","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1745-7254.2005.00019.x","article-title":"Ginsenoside Rg1 reduces MPTP-induced substantia nigra neuron loss by suppressing oxidative stress","volume":"26","author":"Chen","year":"2005","journal-title":"Acta Pharmacol Sin."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB116|cit116","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1111\/j.1745-7254.2006.00331.x","article-title":"Ginsenoside Rg1 inhibits proliferation of vascular smooth muscle cells stimulated by tumor necrosis factor-alpha","volume":"27","author":"Ma","year":"2006","journal-title":"Acta Pharmacol Sin."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB117|cit117","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.neuropharm.2006.10.001","article-title":"Neuroprotective effects of ginsenoside-Rg1 in primary nigral neurons against rotenone toxicity","volume":"52","author":"Leung","year":"2007","journal-title":"Neuropharmacology."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB118|cit118","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1111\/j.1471-4159.2009.06051.x","article-title":"Ginsenoside Rg1 protects against 6-OHDA-induced neurotoxicity in neuroblastoma SK-N-SH cells via IGF-I receptor and estrogen receptor pathways","volume":"109","author":"Gao","year":"2009","journal-title":"J Neurochem."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB119|cit119","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jep.2009.09.038","article-title":"Ginsenoside Rg1 protects against 6-OHDA-induced toxicity in MES23.5 cells via Akt and ERK signaling pathways","volume":"127","author":"Ge","year":"2010","journal-title":"J Ethnopharmacol."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB120|cit120","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.neuropharm.2009.09.002","article-title":"Rg1 protects the MPP+-treated MES23.5 cells via attenuating DMT1 up-regulation and cellular iron uptake","volume":"58","author":"Xu","year":"2010","journal-title":"Neuropharmacology."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB121|cit121","doi-asserted-by":"crossref","first-page":"6158","DOI":"10.1038\/sj.onc.1203173","article-title":"Diverse functions of JNK signaling and c-Jun in stress response and apoptosis","volume":"18","author":"Leppa","year":"1999","journal-title":"Oncogene."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB122|cit122","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.neuint.2008.10.003","article-title":"Rg1 reduces nigral iron levels of MPTP-treated C57BL6 mice by regulating certain iron transport proteins","volume":"54","author":"Wang","year":"2009","journal-title":"Neurochem Int."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB123|cit123","doi-asserted-by":"crossref","first-page":"R871","DOI":"10.1152\/ajpregu.00031.2010","article-title":"Dietary genistein and equol (4\u2032, 7 isoflavandiol) reduce oxidative stress and protect rats against focal cerebral ischemia","volume":"299","author":"Ma","year":"2010","journal-title":"Am J Physiol Regul Integr Comp Physiol."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB124|cit124","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1017\/S0007114507746871","article-title":"Dietary soya intake alters plasma antioxidant status and lipid peroxidation in postmenopausal women with the metabolic syndrome","volume":"98","author":"Azadbakht","year":"2007","journal-title":"Br J Nutr."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB125|cit125","first-page":"12","article-title":"Estrogenic modulation of brain activity: implications for schizophrenia and Parkinson's disease","volume":"27","author":"Cyr","year":"2002","journal-title":"J Psychiatry Neurosci."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB126|cit126","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/ptr.2564","article-title":"Neuroprotective effect of genistein in 6-hydroxydopamine hemi-parkinsonian rat model","volume":"23","author":"Baluchnejadmojarad","year":"2009","journal-title":"Phytother Res."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB127|cit127","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0007114510002291","article-title":"Genistein reduced the neural apoptosis in the brain of ovariectomised rats by modulating mitochondrial oxidative stress","volume":"104","author":"Huang","year":"2010","journal-title":"Br J Nutr."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB128|cit128","doi-asserted-by":"crossref","first-page":"28721","DOI":"10.1074\/jbc.M501092200","article-title":"Tyrosine phosphorylation regulates the proteolytic activation of protein kinase C in dopaminergic neuronal cells","volume":"280","author":"Kaul","year":"2005","journal-title":"J Biol Chem."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB129|cit129","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1212\/01.WNL.0000055899.24594.8E","article-title":"Effect of L-dopa on plasma homocysteine in PD patients: relationship to B-vitamin status","volume":"60","author":"Miller","year":"2003","journal-title":"Neurology."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB130|cit130","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/01.WNF.0000220817.94102.95","article-title":"The controversy concerning plasma homocysteine in Parkinson disease patients treated with levodopa alone or with entacapone: effects of vitamin status","volume":"29","author":"Zesiewicz","year":"2006","journal-title":"Clin Neuropharmacol."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB131|cit131","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1468-1331.2004.00973.x","article-title":"Hyperhomocysteinemia in L-dopa treated Parkinson's disease patients: effect of cobalamin and folate administration","volume":"12","author":"Lamberti","year":"2005","journal-title":"Eur J Neurol."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB132|cit132","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/01.wnf.0000150865.21759.bc","article-title":"The effect of ascorbic acid on the pharmacokinetics of levodopa in elderly patients with Parkinson disease","volume":"27","author":"Nagayama","year":"2004","journal-title":"Clin Neuropharmacol."},{"key":"10.1111\/j.1753-4887.2012.00484.x-BIB133|cit133","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.euroneuro.2005.01.006","article-title":"Hydrosoluble fiber (Plantago ovata husk) and levodopa II: experimental study of the pharmacokinetic interaction in the presence of carbidopa","volume":"15","author":"Fernandez","year":"2005","journal-title":"Eur Neuropsychopharmacol."}],"container-title":["Nutrition Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/nutritionreviews\/article-pdf\/70\/7\/373\/5223878\/nutritionreviews70-0373.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T18:41:57Z","timestamp":1713984117000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/nutritionreviews\/article-lookup\/doi\/10.1111\/j.1753-4887.2012.00484.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5,22]]},"references-count":133,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,7]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1753-4887.2012.00484.x","relation":{},"ISSN":["0029-6643"],"issn-type":[{"value":"0029-6643","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5,22]]}}}